Interestingly, MAPT-FTD was the only genotype with significantly higher CSF Galectin-3 levels compared to C9ORF72- and GRN-mediated FTD [32], and it also displayed the lowest CSF CHIT1 levels [30]. This evidence concerns the gene GRN and frontotemporal dementia.